Modafi nil as a replacement for dextroamphetamine for sustaining alertness in military helicopter pilots

Aviation Space and Environmental Medicine

Volumn 83, Issue 6, 2012, Pages 556-567

  Estrada, Arthur ^a   Kelley, Amanda M ^a   Webb, Catherine M ^a   Athy, Jeremy R ^a   Crowley, John S ^a  

^a U S ARMY AEROMEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Dextroamphetamine; Extended wakefulness; Fatigue; Modafinil; Stimulants; Sustained helicopter operations

Indexed keywords

BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; MODAFINIL;

ADDICTION; ADULT; AEROSPACE MEDICINE; AIRCRAFT; AROUSAL; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SUBSTITUTION; FATIGUE; FEMALE; HUMAN; MALE; SOLDIER; UNITED STATES;

ADULT; AEROSPACE MEDICINE; AIRCRAFT; AROUSAL; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DRUG SUBSTITUTION; FATIGUE; FEMALE; HUMANS; MALE; MILITARY PERSONNEL; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84864417514     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.3129.2012     Document Type: Article

References (38)

1. Akerstedt T, Ficca G. Alertness-enhancing drugs as a countermeasure to fatigue in irregular work hours. Chronobiol Int 1997; 14: 145 - 58.
2. Akerstedt T, Torsvall L. Napping in shift work. Sleep 1985; 8: 105 - 9.
3. Babkoff H, Krueger GP. Use of stimulants to ameliorate the effects of sleep loss during sustained performance. Mil Psychol 1992; 4: 191 - 205.
4. Baranski JV, Cian C, Esquivie D, Pigeau RA, Raphel C. Modafi nil during 64 hr of sleep deprivation: dose-related effects on fatigue, alertness, and cognitive performance. Mil Psychol 1998; 10: 173 - 93.
5. Bonnet MH. Dealing with shift work: physical fi tness, temperature, and napping. Work Stress 1990; 4: 261 - 74.
6. Bonnet MH. The effect of varying prophylactic naps on performance, alertness and mood throughout a 52-hour continuous operation. Sleep 1991; 14: 307 - 15.
7. Buguet A, Moroz DE, Radomski MW. Modafi nil - medical considerations for use in sustained operations. Aviat Space Environ Med 2003; 74: 659 - 63.
8. Caldwell JA. Effi cacy of stimulants for fatigue management: the effects of Provigil w and Dexedrine w on sleep-deprived aviators. Transp Res Part F Traffi c Psychol Behav 2001; 4: 19 - 37.
9. Caldwell JA Jr, Caldwell JL, Smythe NK 3rd, Hall KK. A doubleblind placebo-controlled investigation of the effi cacy of modafi nil for sustaining the alertness and performance of aviators: a helicopter simulator study. Psychopharmacology (Berl) 2000; 150: 272 - 82.
10. Caldwell JA, Roberts KA, Jones HD. Evaluating performance effects of a medication (Dexedrine w) in the simulator versus aircraft environment. Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory; 1999. USAARL Report 99-15.
11. Caldwell JA, Smythe NK, Leduc PA, Caldwell JL. Effi cacy of dexedrine for maintaining aviator performance during 64 hours of sustained wakefulness: a simulator study. Aviat Space Environ Med 2000; 71: 7 - 18.
12. Caldwell JA, Smythe NK, LeDuc PA, Prazinko BF, Caldwell JL, et al. The effi cacy of dexedrine for the sustainment of helicopter pilot performance during 64 hours of continuous wakefulness. Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory; 1999. USAARL Technical Report No. 99-01.
13. Chua D, Goh BC, Lee HS, Tey LK, Tan YY, Lai KW. The effi cacy of modafi nil in maintaining alertness level in males of Chinese ethnicity in a 40-hour continuous wakefulness sleep deprivation study [Abstract]. 2010. Presented at the 58th International Congress of Aviation and Space Medicine, 10-14 October, Singapore. International Academy of Aviation and Space Medicine; 2010; available at http://iaasm.org/documents/AbstractsSingapore2010.pdf.
14. De Valck E, Cluydts R, Pirrera S. Effect of cognitive arousal on sleep latency, somatic and cortical arousal following partial sleep deprivation. J Sleep Res 2004; 13: 295 - 304.
15. Eddy D, Storm W, French J, Barton E, Cardensa R. An assessment of modafi nil for vestibular and aviation-related effects. Brooks City-Base, TX: Air Force Research Laboratory; 2005. ARFL Report 2005-0129.0.
16. Emmonson DL, Vanderbeek RD. The use of dextroamphetamine in support of tactical air operations during Operation Desert Shield/Storm. [Abstract.] Aviat Space Environ Med 1993; 64: 421.
17. ePOCRATES w ONLINE. Drug monographs. Retrieved 28 November 2007 from https://online.epocrates.com/.
18. Estrada A, Kelley AM, Webb CM, Athy JR, Crowley JS, et al. A comparison of the effi cacy of modafi nil and dextroamphetamine as alertness promoting agents in aviators performing extended operations. Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory; 2011. USAARL Report No. 2011-05.
19. Gerrard P, Malcolm R. Mechanisms of modafi nil: a review of current research. Neuropsychiatr Dis Treat 2007; 3: 349 - 64.
20. Gurtman CG, Broadbear JH, Redman JR. Effects of modafi nil on simulator driving and self-assessment of driving following sleep deprivation. Hum Psychopharmacol 2008; 23: 681 - 92.
21. Kellogg RS, Kennedy RS, Graybiel A. Motion sickness symptomatology of labyrinthine defective and normal subjects during zero gravity maneuvers. Aerosp Med 1965; 36: 315 - 8.
22. Killgore WDS. Effects of sleep deprivation and morningnesseveningness traits on risk taking. Psychol Rep 2007; 100: 613 - 26.
23. Killgore WDS, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ. Effects of dextroamphetamine, caffeine, and modafi nil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 2008; 17: 309 - 21.
24. LeDuc PA, Rowe TL, Martin CM, Curry IP, Wildzunas RM, et al. Performance sustainment of two man crews during 87 hours of extended wakefulness with stimulants and napping. Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory; 2009. USAARL Report No. 2009-04.
25. McNair DM, Lorr M, Droppleman LF. Manual: Profi le of Mood States - Revised. San Diego: Education and Industrial Testing Service; 1992.
26. Mignot E, Nishino S, Guilleminault C, Dement WC. Modafi nil binds to the dopamine uptake carrier site with low affi nity. Sleep 1994; 17: 436 - 7.
27. Newhouse PA, Belenky G, Thomas M, Thorne D, Sing HC, Fertig J. The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation. Neuropsychopharmacology 1989; 2: 153 - 64.
28. Park GD, Ware JC, May JF, Rosenthal TJ, Guibert MR, Allen RW. The effects of sleep deprivation on simulator driving as compared with other psychomotor tests. The 4th International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design Proceedings; July 9-12, 2007; Stevenson, WA. Washington, DC: Transportation Research Board; 2007:257-64. Available at http://trid.trb.org/view. aspx?id=814596.
29. Penetar D, McCann U, Thorne D, Kamimori G, Galinski C, et al. Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology (Berl) 1993; 112: 359 - 65.
30. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, et al. Modafi nil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res 1995; 4: 212 - 28.
31. Ramsey CS, Werchan PM, Isdahl WM, Fischer J, Gibbons JA. Acceleration tolerance at night with acute fatigue and stimulants. Aviat Space Environ Med 2008; 79: 769 - 73.
32. Sicard B, Jouve E, Blin O. Risk propensity assessment in military special operations. Mil Med 2001; 166: 871 - 4.
33. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafi nil in healthy volunteers. Psychopharmacology (Berl) 2003; 165: 260 - 9.
34. Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, et al. Effects of modafi nil on dopamine and dopamine transporters in the male human brain. JAMA 2009; 301: 1148 - 54.
35. Wesensten NJ. Effects of modafi nil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 2006; 12: 2457 - 71.
36. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ. Maintaining alertness and performance during sleep deprivation: modafi nil versus caffeine. Psychopharmacology (Berl) 2002; 159: 238 - 47.
37. Wesensten NJ, Killgore WDS, Balkin TJ. Performance and alertness effects of caffeine, dextroamphetamine, and modafi nil during sleep deprivation. J Sleep Res 2005; 14: 255 - 66.
38. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787 - 94.